Global Radiopharmaceuticals in Nuclear Medical Sales Market Report 2021

1 Radiopharmaceuticals in Nuclear Medical Market Overview
    1.1 Radiopharmaceuticals in Nuclear Medical Product Scope
    1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
        1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2016 & 2021 & 2027)
        1.2.2 Diagnostic Radiopharmaceuticals
        1.2.3 Therapy Radiopharmaceuticals
        1.2.4 Enriched Stable Isotopes
    1.3 Radiopharmaceuticals in Nuclear Medical Segment by Application
        1.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Diagnostic Application
        1.3.3 Therapeutic Application
        1.3.4 Research
        1.3.5 Pharmaceutical
        1.3.6 Industrial
    1.4 Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Radiopharmaceuticals in Nuclear Medical Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Radiopharmaceuticals in Nuclear Medical Price Trends (2016-2027)

2 Radiopharmaceuticals in Nuclear Medical Estimates and Forecasts by Region
    2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2016-2021)
        2.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2016-2021)
    2.3 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
        2.4.2 Europe Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
        2.4.3 China Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
        2.4.4 Japan Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)
        2.4.6 India Radiopharmaceuticals in Nuclear Medical Estimates and Projections (2016-2027)

3 Global Radiopharmaceuticals in Nuclear Medical Competition Landscape by Players
    3.1 Global Top Radiopharmaceuticals in Nuclear Medical Players by Sales (2016-2021)
    3.2 Global Top Radiopharmaceuticals in Nuclear Medical Players by Revenue (2016-2021)
    3.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2020)
    3.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Company (2016-2021)
    3.5 Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type
    4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Type (2016-2021)
        4.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2016-2021)
        4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2016-2021)
        4.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2016-2021)
    4.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2022-2027)
        4.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2022-2027)
        4.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2022-2027)

5 Global Radiopharmaceuticals in Nuclear Medical Market Size by Application
    5.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Review by Application (2016-2021)
        5.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2016-2021)
        5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2016-2021)
        5.1.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2016-2021)
    5.2 Global Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2022-2027)
        5.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2022-2027)
        5.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2022-2027)

6 North America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    6.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Company
        6.1.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        6.1.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    6.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        6.2.1 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        6.2.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    6.3 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        6.3.1 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2016-2021)
        6.3.2 North America Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2022-2027)

7 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    7.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Company
        7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    7.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        7.2.1 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    7.3 Europe Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    8.1 China Radiopharmaceuticals in Nuclear Medical Sales by Company
        8.1.1 China Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        8.1.2 China Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    8.2 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        8.2.1 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        8.2.2 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    8.3 China Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        8.3.1 China 166 Sales Breakdown by Application (2016-2021)
        8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    9.1 Japan Radiopharmaceuticals in Nuclear Medical Sales by Company
        9.1.1 Japan Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        9.1.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    9.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        9.2.1 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    9.3 Japan Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    10.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Company
        10.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        10.1.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    10.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        10.2.1 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Radiopharmaceuticals in Nuclear Medical Market Facts & Figures
    11.1 India Radiopharmaceuticals in Nuclear Medical Sales by Company
        11.1.1 India Radiopharmaceuticals in Nuclear Medical Sales by Company (2016-2021)
        11.1.2 India Radiopharmaceuticals in Nuclear Medical Revenue by Company (2016-2021)
    11.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type
        11.2.1 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2016-2021)
        11.2.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Type (2022-2027)
    11.3 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application
        11.3.1 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2016-2021)
        11.3.2 India Radiopharmaceuticals in Nuclear Medical Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medical Business
    12.1 Bracco Imaging
        12.1.1 Bracco Imaging Corporation Information
        12.1.2 Bracco Imaging Business Overview
        12.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
        12.1.5 Bracco Imaging Recent Development
    12.2 Cambridge Isotope Laboratories
        12.2.1 Cambridge Isotope Laboratories Corporation Information
        12.2.2 Cambridge Isotope Laboratories Business Overview
        12.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
        12.2.5 Cambridge Isotope Laboratories Recent Development
    12.3 Cardinal Health
        12.3.1 Cardinal Health Corporation Information
        12.3.2 Cardinal Health Business Overview
        12.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
        12.3.5 Cardinal Health Recent Development
    12.4 Medtronic
        12.4.1 Medtronic Corporation Information
        12.4.2 Medtronic Business Overview
        12.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Products Offered
        12.4.5 Medtronic Recent Development
    12.5 Eczacibasi-Monrol
        12.5.1 Eczacibasi-Monrol Corporation Information
        12.5.2 Eczacibasi-Monrol Business Overview
        12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
        12.5.5 Eczacibasi-Monrol Recent Development
    12.6 Fujifilm Holdings Corporation
        12.6.1 Fujifilm Holdings Corporation Corporation Information
        12.6.2 Fujifilm Holdings Corporation Business Overview
        12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
        12.6.5 Fujifilm Holdings Corporation Recent Development
    12.7 GE Healthcare (Subsidiary Of General Electric Company)
        12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
        12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
        12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
        12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
    12.8 IBA Group
        12.8.1 IBA Group Corporation Information
        12.8.2 IBA Group Business Overview
        12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
        12.8.5 IBA Group Recent Development
    12.9 Lantheus Medical Imaging
        12.9.1 Lantheus Medical Imaging Corporation Information
        12.9.2 Lantheus Medical Imaging Business Overview
        12.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
        12.9.5 Lantheus Medical Imaging Recent Development
    12.10 Nordion
        12.10.1 Nordion Corporation Information
        12.10.2 Nordion Business Overview
        12.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
        12.10.5 Nordion Recent Development
    12.11 Ntp Radioisotopes
        12.11.1 Ntp Radioisotopes Corporation Information
        12.11.2 Ntp Radioisotopes Business Overview
        12.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Products Offered
        12.11.5 Ntp Radioisotopes Recent Development
    12.12 Siemens Healthcare
        12.12.1 Siemens Healthcare Corporation Information
        12.12.2 Siemens Healthcare Business Overview
        12.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Products Offered
        12.12.5 Siemens Healthcare Recent Development
    12.13 Taiyo Nippon Sanso Corporation
        12.13.1 Taiyo Nippon Sanso Corporation Corporation Information
        12.13.2 Taiyo Nippon Sanso Corporation Business Overview
        12.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
        12.13.5 Taiyo Nippon Sanso Corporation Recent Development
    12.14 Urenco Limited
        12.14.1 Urenco Limited Corporation Information
        12.14.2 Urenco Limited Business Overview
        12.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Products Offered
        12.14.5 Urenco Limited Recent Development
    12.15 Rotem Industries
        12.15.1 Rotem Industries Corporation Information
        12.15.2 Rotem Industries Business Overview
        12.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Products Offered
        12.15.5 Rotem Industries Recent Development

13 Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Analysis
    13.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
    13.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Radiopharmaceuticals in Nuclear Medical Distributors List
    14.3 Radiopharmaceuticals in Nuclear Medical Customers

15 Market Dynamics
    15.1 Radiopharmaceuticals in Nuclear Medical Market Trends
    15.2 Radiopharmaceuticals in Nuclear Medical Drivers
    15.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
    15.4 Radiopharmaceuticals in Nuclear Medical Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer